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The main topic of this paper is evaluating a system that uses the expected value of experimentation for discovering causal pathways in
gene expression data. By experimentation we mean both interventions (e.g., a gene knock-out experiment) and observations (e.g., pas-
sively observing the expression level of a ‘‘wild-type’’ gene). We introduce a system called GEEVE (causal discovery in Gene Expression
data using Expected Value of Experimentation), which implements expected value of experimentation in discovering causal pathways
using gene expression data. GEEVE provides the following assistance, which is intended to help biologists in their quest to discover
gene-regulation pathways:
• Recommending which experiments to perform (with a focus on ‘‘knock-out’’ experiments) using an expected value of experimentation
(EVE) method.
• Recommending the number of measurements (observational and experimental) to include in the experimental design, again using an
EVE method.
• Providing a Bayesian analysis that combines prior knowledge with the results of recent microarray experimental results to derive pos-
terior probabilities of gene regulation relationships.In recommending which experiments to perform (and how many times to repeat them) the EVE approach considers the biologists
preferences for which genes to focus the discovery process. Also, since exact EVE calculations are exponential in time, GEEVE incor-
porates approximation methods. GEEVE is able to combine data from knock-out experiments with data from wild-type experiments to
suggest additional experiments to perform and then to analyze the results of those microarray experimental results. It models the pos-
sibility that unmeasured (latent) variables may be responsible for some of the statistical associations among the expression levels of the
genes under study.
To evaluate the GEEVE system, we used a gene expression simulator to generate data from speciﬁed models of gene regulation. Using
the simulator, we evaluated the GEEVE system using a randomized control study that involved 10 biologists, some of whom used
GEEVE and some of whom did not. The results show that biologists who used GEEVE reached correct causal assessments about gene
regulation more often than did those biologists who did not use GEEVE. The GEEVE users also reached their assessments in a more
cost-eﬀective manner.
 2006 Published by Elsevier Inc.
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Most research on causal discovery using causal net-
works has been based on using passive observational data
[1–4]. There are limitations in learning causal relationships
from observational data only. For example, if the generat-
ing process contains a latent factor (confounder) that inﬂu-
ences two variables, it can be diﬃcult, if not impossible, to
learn the causal relationships between those two variables
from observational data alone.
To uncover such causal relationships, a scientist general-
ly needs to design a study that involves manipulating a var-
iable (or variables) and then observing the changes (if any)
in other variables of interest. In such an experimental
study, one or more variables are manipulated and the ef-
fects on other variables are measured. On the other hand,
observational data result from passive (i.e., non-interven-
tional) measurement of some system, such as a cell. In gen-
eral, both observational and experimental data may exist
on a set of variables of interest. Limited time and funds re-
strict the number of variables that can be manipulated and
the number of experimental repeats that can be collected
for the control and experimental groups. For example, a
molecular biologist who is interested in discovering the
causal pathway of the genes involved in galactose metabo-
lism ﬁrst has to select the genes he or she is interested in
understanding at a causal level. These genes are usually
selected based on previously published results or by the
molecular biologists personal interest. Many issues are
considered in determining the number of experimental re-
peats to obtain for each variable in the study design. Hav-
ing more experimental repeats will typically tighten the
statistical conﬁdence intervals in the data analysis. Consid-
ering available time, budget, and other constraints, the
biologist will make a decision about the number of exper-
imental repeats to obtain.
Developing causal analysis methods is a key focus of
several ﬁelds. In statistics, jointly with medicine, issues
related to randomized clinical trials (RCTs) are studied,
including methods for ﬁnding an optimal number of cases
using stopping rules [5–7]. In molecular biology, develop-
ing techniques that generate eﬃcient experimental designs
for high throughput methods, such as cDNA microarrays,
is gaining interest [8,9]. In artiﬁcial intelligence, techniques
using graphical models have been used to model experi-
mentation and have been applied to suggest the next exper-
iment for causal discovery [10–12].
All these prior approaches have made contributions to
eﬃcient causal study design. They are not, however, sensi-
tive to issues of limited resources and experimenter prefer-
ences. The research reported here is concerned with
evaluating a decision-analytic system that addresses these
issues in helping a biologist design and analyze studies of
cellular pathways using high throughput sources of data.
In particular, this paper concentrates on the design and
analysis of cDNA microarray studies for uncovering gene
regulation pathways. The fundamental methodology,however, is applicable to analyzing other high throughput
data sources, such as the measurement of protein-levels,
which is a rapidly developing area of biology.
Diﬀerent tools have been developed to assist systems
biology research using microarray data [4,10,11]. Unfortu-
nately, there are limited studies that evaluate how useful
these tools are to the biologists. In this paper, we provide
an evaluation of the GEEVE system with 10 biologists,
some of whom used GEEVE and some of whom did not.
In this section, we shortly provide background of gene
array chips and give an overview of the GEEVE system.
1.1. Gene array chips
Three major gene-expression measurement technologies
are currently available for measuring the expression levels
of many genes at once. One is called a cDNA microarray,
or simply DNA microarray [13]; another is called an oligo-
nucleotide array, or GeneChip [14]; and a third technique is
called serial analysis of gene expression (SAGE). We con-
centrate in this paper on the ﬁrst two techniques, since they
are high throughput methods, whereas SAGE is a more
time consuming method. The DNA microarray technique
uses user-deﬁnable probes1 of DNA microarray, and the
oligonucleotide array uses small oligonucleotide (usually
200 or 300 bases) as factory-built probes.
1.2. Problem description
A gene expression study using DNA microarrays usually
involves two major steps. The ﬁrst step typically consists of
performing initial experiments to narrow the set of genes to
study in more detail. The experimenter can avoid this ﬁrst
step if he or she already knows the speciﬁc set of genes of
interest. Since the functions of many genes are not known,
the ﬁrst step is usually necessary. A number of microarrays
will be assigned to hybridize with a pool of controlled cells
and experimental cells. By examining the genes that are dif-
ferentially expressed in these two groups of cells, the exper-
imenter can decide which genes to study further. After
choosing those genes, the experimenter has to produce an
experimental design for further study how those genes are
functionally related to each other.
2. GEEVE system
This chapter describes the issues related to the imple-
mentation of the GEEVE system (causal discovery in Gene
Expression data using Expected Value of Experimenta-
tion). Tong and Koller [12] used a single-case approach
to recommend to the experimenter the best possible pair-
wise relationship for further investigation. In gene expres-
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one experiment at a time. Often it is more eﬃcient to repeat
a given experiment multiple times in parallel, rather than to
repeat the experiment sequentially over time.
Tong and Koller [12] and Ideker et al. [11] used edge
entropy loss functions to search for the next best experi-
ment to perform. This approach can be useful when the
experimenter is performing a ﬁrst-phase study to select
the genes without any preference toward the relationships
among the genes. After the ﬁrst-phase study, however,
the experimenter will usually have some preference for
which genes to study in greater detail. As more gene expres-
sion experiments (studies) are performed, the experimenter
will reﬁne his or her preferences about the relationships to
study in more and more detail. Consequently, a recommen-
dation system that incorporates the preferences of the
experimenter seems desirable.
GEEVE allows for repeats of an experiment, and as just
mentioned it can be sensitive to an experimenters prefer-
ences for which genes to study. These improvements osten-
sibly make GEEVE more applicable to real-world design of
gene expression experiments. GEEVE also incorporates an
eﬃcient causal discovery method that is based on an exten-
sion of a causal discovery algorithm [15].
The GEEVE system consists of two modules called the
causal Bayesian network update (CBNU) module and the
decision tree generation and evaluation (DTGE) module
(Fig. 1). The CBNU module uses an algorithm called
Implicit Latent Variable Scoring (ILVS) method [15] toFig. 1. The GEEVE system. The box with the thick line represents the
GEEVE system. Boxes in GEEVE represent system modules. Boxes with
wavy lines on the bottom represent outputs from GEEVE. The Exper-
iments oval is an object that is outside of GEEVE. The ovals on the
GEEVE border represent objects that communicate with GEEVE from
the outside.causally analyze the current microarray data in light of
the users prior beliefs about causal relationships among
the genes under study. The DTGE module evaluates a deci-
sion tree that was generated based on the results of the
CBNU module and the experimenters preferences, which
are expressed with GEEVE as a utility function. Finally
(under assumptions) the best possible experiments are rec-
ommended to the experimenter. The experimenter then
chooses the next experiment to perform, which may or
may not be the one suggested by GEEVE. When the results
are available, they can be submitted to the CBNU module
for a new round of analysis.
2.1. Updating causal bayesian networks
This chapter describes a new method to evaluate causal
Bayesian networks using a mixture of observational and
experimental data. The algorithm described in the current
chapter is then incorporated into the GEEVE system.
A causal Bayesian network (or causal network for short)
is a Bayesian network in which each arc is interpreted as a
direct causal inﬂuence between a parent node (variable)
and a child node, relative to the other nodes in the network
[16]. Fig. 2 illustrates the structure of a hypothetical causal
Bayesian network structure containing ﬁve nodes that rep-
resent genes. The probabilities associated with this causal
network structure are not shown.
The causal network structure in Fig. 2 indicates, for
example, that the Gene1 can regulate (causally inﬂuence)
the expression level of the Gene3, which in turn can regu-
late the expression level of the Gene5. The causal Markov
condition gives the conditional independence relationships
speciﬁed by a causal Bayesian network:
A variable is independent of its non-descendants (i.e., non-
eﬀects) given its parents (i.e., its direct causes).
The causal Markov condition permits the joint distribu-
tion of the n variables in a causal Bayesian network to be
factored as follows [16]:
Pðx1; x2; . . . ; xnjKÞ ¼
Yn
i¼1
P ðxijpi;KÞ; ð1Þ
where xi denotes a state of variableXi, pi denotes a joint
state of the parents of Xi, and K denotes background
knowledge.Fig. 2. A causal Bayesian network that represents a portion of a
hypothetical gene-regulation pathway.
Fig. 3. Six local causal hypotheses.
Fig. 5. Specifying the experimental condition decision branch.
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among the structures (Fig. 3). The causal networks in an
equivalence class are statistically indistinguishable for any
observational and experimental data on X and Y where
H represents a latent variable.
Using the previously published structure scoring method
[1,17], we introduced the ILVS method to score the six
hypotheses in Fig. 3 [15,18]. Local ILVS Method (LIM)
was introduced to score structures with more than pairwise
variables [15]. A high level pseudo code is given in Fig. 4.
More detail information of ILVS and LIM could be found
at Yoo and Cooper [19] and Yoo [20].
2.2. GEEVE utility model
GEEVE is capable of incorporating an experimenters
utility model [20]. In the research reported in this paper,
we did not explore this aspect of GEEVE, because we
empirically compare GEEVEs performance to other meth-
ods that do not allow modeling utilities ﬂexibly. Instead,
we used the following utility assumptions, where EXYi de-
notes the node pair X and Y with causal relationship Ei:
(1) For all pairs (X,Y), U (X,Y) = 0.5, which means that
all gene pairs are of equal interest; (2) UðEXYi jEXYj Þ ¼ 1
for all i = j, which that when the predicted structure EXYi
matches the generating structure EXYj , the utility is assigned
to be the highest possible value (=1.0); (3)
UðEXYi jEXYj Þ ¼ 0:5 for all EXYi and EXYj that have equivalent
causal relationships with respect to a latent confounder,
that is, EXY1 and E
XY
4 , E
XY
2 and E
XY
5 , and E
XY
3 and E
XY
6 are
equivalent causal relationships with respect to latent con-
founder; and otherwise (4) UðEXYi jEXYj Þ ¼ 0.
The GEEVE utility for reporting the relationship EXYi to
the user (experimenter) is derived as follows. The weights
wij ¼ UðEXYi jEXYj Þ are used as a shorthand notation.Fig. 4. A high level pseudo code of LIM. Note that S is a local structure in whic
include only k variables).The following term is then derived: qi ¼P
jwij  P ðEXYj jD;KÞ. Finally, the experimenters utility for
discovering a novel and interesting causal relationship is
calculated as qiÆU(X,Y).
2.3. Generating a decision tree
Based on the experimenters utility speciﬁcation and the
causal Bayesian network output (generated by LIM [15]
through a local heuristic search and model selection) the
GEEVE system builds a decision tree and evaluates it.
GEEVE concentrates on pairwise relationships of genes
and generates Fig. 5, where Rj represents a pair of genes,
np represents the number of pairs among the genes, m rep-
resents a maximum measurements that are obtained for an
experimental study, neh represents the experimental condi-
tions (explained later in this section) to impose for dataset
simulation, tEi represents the situation where the true
structure is Ei, and qi is deﬁned as in Section 2.2.
For the decision tree shown in Fig. 5, assuming that
there are at most l states for each variable and assuming
there are k variables modeled in LIMs local structure
(see Fig. 4), then the number of possible datasets nd 6 lkm,
which is exponential in the number m of microarray exper-
iments (cases). LIM uses a simulation method [21] to makeh it does not include all modeled variables (recall that the set X is limited to
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track of the highest scoring local structure given an exper-
imental condition and a dataset D. Using the highest
scored local structure, LIM generates possible experimen-
tal results such as D01, D
0
2, . . .,D
0
nd [21].
The computation of the decision tree evaluation is expo-
nential in the number of microarray experiments (cases).
Therefore, we need an approximation method to evaluate
the decision tree. Several diﬀerent approximation methods
are available with some assumptions [22,23].
Heckerman et al. [22] introduced a non-myopic approx-
imation method assuming that for a large decision tree, the
central limit theorem holds. The method was non-myopic
in the number of chance nodes but not in the number of
decision nodes.
Chavez and Henrion [23] assumed additive expected
utility independence and used linear regression to estimate
the expected value of perfect information (EVPI) and
expected value of information (EVI). However, Heckerman
et al. [22] and Chavez and Henrion [23] approximations are
not suitable with large number of decision branches be-
cause they assume binary decision nodes. Thus, we use a
random heuristic search to approximate the expected value
of experimentation. For detail information about the heu-
ristic search, refer to Yoo and Cooper [24].
3. Related work
The GEEVE system incorporates an experimenters
preferences into a decision model to give recommendations
about designing a gene-expression experimental study. The
decision model it uses is based on decision theory [25,26].
Many diﬀerent ﬁelds concentrate on study design for causal
discovery. Traditionally, in statistics and medicine, re-
search on causal discovery is actively pursued in research
on controlled trials [5,6,27]. In computer science, causal
discovery is also an active research topic, especially in the
machine learning community [1–3,20,28,29]. In biology, re-
cent microarray technologies have fueled a ﬁeld known as
systems biology, which seeks to discover causal relation-
ships among a large number of genes and other cellular
constituents [30,31]. In this section, we will review work
related to this paper, concentrating especially on the ﬁelds
just mentioned.
3.1. Genetic pathway models
Before describing pathway models, we ﬁrst place them in
the context of gene clustering methods, which have been
very popular the last few years. Indeed most of the early
work on gene expression data analyses used clustering
methods. Gene expression levels that were measured by
cDNA microarray in the yeast cell-division cycle were ana-
lyzed for the ﬁrst time using a cluster analysis [30]. A clus-
ter analysis typically searches for groups of genes that show
similar expression pattern among diﬀerent experimental
conditions. Other analyses followed using similar clusteranalyses applied to microarray data [32–35]. Cluster and
classiﬁcation analyses do not necessarily provide causal
information, which is at the heart of gene pathway discov-
ery. On the other hand, knowledge of causal pathways can
be used to produce a causal clustering of the genes.
Tsang [36] and Dutilh [37] each give a review of genetic
networks. Reviews that are focused more on modeling
methods are given by de Jong [38] and—especially on
Bayesian network—Friedman [39]. A thorough review
based on biological context was published by Smolen
et al. [40], who suggested that current microarray tech-
niques are limited in delineating intracellular signaling
pathways[41]. Smolen et al. [40] argues that since micro-
array technology is measuring an average expression level
of a gene among millions of cells, there is little we can learn
about gene-regulation pathways information from the
data. We will discuss this issue in Section 5.2 with respect
to latent variable detection.
3.2. Experimentation recommendation models
Computational models of scientiﬁc discovery were
actively studied in artiﬁcial intelligence (in conjunction
with psychology) in the late 1980s [42]. In molecular biolo-
gy in particular, Karp [43] created systems in bacterial gene
regulation that could describe the initial conditions of an
experiment, generate a hypothesis, and reﬁne it.
An extension of supervised learning, active learning was
applied to learning causal Bayesian networks in scientiﬁc
discovery [12]. Tong and Koller used edge entropy loss
functions and a myopic search to recommend the next best
experiment to perform. Their main assumptions are: (1)
discrete variables only; (2) no missing data; and (2) no
modeling of latent (hidden) variables. They modeled
manipulation and selection using the manipulation repre-
sentation in Cooper and Yoo [44].
Ideker et al. [11] used binary networks to model the per-
turbation on a gene network and used entropy loss function
to recommend the next best perturbation to perform, where
perturbation on a genemeans forcing the gene to take a ﬁxed
value. They implemented twomethods to infer a genetic net-
work built from a gene expression dataset. To implement the
genetic network, they used a deterministic Boolean model.
This model is a simpliﬁed version of Bayesian networks
(see Section 3.1) where all variables are binary and all condi-
tional distribution tables are simply truth tables.
Similar Boolean networks were used to model the exper-
iments involving the gene networks, and the set-covering
method was used to recommend the next best experiment
for more than one experimental repeat [10]. Karp et al.,
used a Boolean circuit model of a biological pathway [45]
to model experimentation.
The results of Yoo and Cooper [24] show that the
GEEVE system gives better results than systems of Ideker
et al. [11] and Tong and Koller [12] (1) in learning the gen-
erating models of gene regulation and (2) in recommending
experiments to perform.
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This section describes an evaluation of the GEEVE sys-
tem. In the evaluation, we used a simulator to generate
gene expression data and compared the performance of
10 biologists, some of whom used GEEVE and some of
whom did not.
4.1. Simulator for the evaluation
Only a few gene expression simulation systems are cur-
rently available [46–48]. Limited functions are available
in most of the systems because they are in their early devel-
opment stages. For example, Tomita et al. [46] simulate a
cell by developing a computer program shell that can exe-
cute any speciﬁed cell model. But the system is limited in its
(1) available cell models, (2) exporting the gene expression
levels to a ﬁle, and (3) modeling of measurement errors.
We used the Scheines and Ramsey [47] simulator system
(which we will call the SR Simulator) to generate gene
expression data. The SR simulator models genes within a
cell and incorporates biological variance, such as that due
to signal loss or gene mutation, as well as measurement er-
ror. The simulator uses a user-deﬁned number of cells in
each probe (we set each probe to contain 100,000 cells in
this study). It allows measurement at diﬀerent time points
and uses the following so called Glass function [49] to up-
date an expression level of a gene X:
eX t ¼ eX t1þ rate½eX t1þF X ðcauses ofðX tÞ nX t1Þþ eX ;
ð2Þ
where Xt represents the gene X at time t and eXt represents
the gene expression level of the gene X at time t,
0 < rate 6 1, causes_of(Xt) are the direct causes of Xt in
the model, ‘‘n’’ is the set diﬀerence operator, eX is an error
term drawn from a given probability distribution, and FX is
a binary function speciﬁed by the user [49]. Binary func-
tions have been used to model natural phenomena includ-
ing gene causal pathway [50]. Also note that the model
used in this evaluation study contain only a one-stage
time-lag, an example of this is shown in Fig. 6, i.e., if a gene
has a causal relationship with another gene, it means the
relationship is modeled as in Fig. 6.Fig. 6. A one-stage time-lag model. A:0 represents the expression level of
gene A at current time and A:1 represents the expression level of gene A at
one time-step before the current time.A burn-in period is desirable in applying the SR Simula-
tor. In particular, for the simulated networks discussed in
this section (1) it is often after 80 time lags that the most
interesting interactions start among the modeled genes;
and (2) the simulated system usually goes into a steady
state after 300 time lags. Therefore we used 80 time lags
for a burn-in period for evaluation study reported here.
4.2. Evaluation with a case-control study
We created a simulator that models a gene regulation
pathway based on assessments from a molecular biologist,
Dr. Martin Schmidt, who has many years of research expe-
rience related to gene regulation pathways in yeast, espe-
cially in pathways that involve SNF1 protein kinase [51–
53]. With my technical assistance, Dr. Schmidt developed
a model of the SNF1 protein kinase pathway for use by
the SR simulator described in next section.
4.2.1. Simulated SNF1 protein kinase pathway
The structure of the gene-regulatory simulation model
that we used is shown in Fig. 7. This model was generated
using only one time-lag point as shown in Fig. 6. Thus, if a
gene has a causal relationship with another gene in Fig. 7,
it means that the relationship is modeled as in Fig. 6. In
Fig. 7 the dotted lines represent the causal relationships
that are biologically plausible but not biologically certain.
SSG* represents a group of genes, i.e., SIP1, SIP2, and
GAL83. SSG was modeled in the simulator but was hidden
from the participants in the study that is the expression le-
vel of SSG was not provided to the participants. Having a
latent SSG in the model simulates (in limited way) a real
microarray experiment in that there can be gene expression
levels that are not measured.
eX in Eq. (2) was estimated from the cDNA microarray
dataset of Gasch et al. [54] and rate was estimated as 0.5 by
consulting with Dr. Schmidt. FX (also assessed fromFig. 7. SNF1 simulation pathway model. Dotted lines represent the causal
relationships that are biologically plausible, but need further investigation.
SSG* represents a group of genes, i.e., SIP1, SIP2, and GAL83. SSG was
modeled in the simulator but was hidden to the participants in the control
study; i.e., the expression level of SSG was not provided to the
participants.
Table 1
The values of FX used in Eq. (2) for simulations involving the SNF1 protein kinase pathway (0 = not expressed; 1 = expressed)
(a) GLC7 and SNF4
GLC7 = 0 GLC7 = 1
SNF4 0 1
(b) GLC7/REG1/SNF1/SNF4/SSG and CAT8 (R0: REG1 = 0, R1: REG1 = 1, S0: SSG1 = 0, and S1: SSG1 = 1)
GLC7 = 0 GLC7 = 1
SNF4 = 0 SNF4 = 1 SNF4 = 0 SNF4 = 1
SNF1 = 0 SNF1 = 1 SNF1 = 0 SNF1 = 1 SNF1 = 0 SNF1 = 1 SNF1 = 0 SNF1 = 1
R0 R1 R0 R1 R0 R1 R0 R1 R0 R1 R0 R1 R0 R1 R0 R1
S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1 S0 S1
CAT8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 1 0 1
(c) CAT8 and SIP4
CAT8 = 0 CAT8 = 1
SIP4 0 1
(d) CAT8/SIP4 and ICL1/JEN1/PCK1
CAT8 = 0 CAT8 = 1
SIP4 = 0 SIP4 = 1 SIP4 = 0 SIP4 = 1
ICL1 0 1 1 1
JEN1 0 1 1 1
PCK1 0 1 1 1
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Fig. 8. Phases in the control study. All participants are asked to ﬁnish up to Phase 5. (A) Phases 0 and 1. Phase 0 just assesses participants prior
knowledge of predeﬁned genes. Diﬀerent than phases 2 through 5, phase 1 provides participants with initial microarray experiment results. (B) Phases 2
through 5. Diﬀerent than in Phase 1, in Phase 2 through Phase 5 participants have to request microarray experiments based on microarray experimental
results collected so far.
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shows the truth table of Glass function that is used in the
simulator. For example, in Table 1A, when GLC7 is
knocked out (GLC7 = 0), then the entire system is shut
down by regulating all the other genes not to express
themselves.
4.2.2. Study design for experiments involving the SNF1
protein kinase pathway
Ten biology faculty members, post-docs, and graduate
students were recruited for this study and oﬀered $50 per
hour of participation. The biologists expressed at least
some knowledge of the SNF1 protein kinase pathway.
We randomly divided these study participants into two
groups: (1) a control group that did not use GEEVE, and
(2) an intervention group that used GEEVE. All partici-
pants were able to obtain the gene expressions levels for
the nine genes (SSG was hidden from the participants) in
Fig. 7 under the following experimental conditions:2
• a wild-type experiment (i.e., no genes were knocked out)
with glucose present;2 There could be other experimental conditions, such as over-expressing
a gene, knocking out more than two genes at a time, or setting diﬀerent
environmental conditions, but this initial study is restricted to the
experimental conditions listed.• a knock-out experiment (with glucose present) for which
a single gene (selected from among the nine genes in
Fig. 7) was knocked out.
All participants could request up to a total of 50measured
microarray chips over all ﬁve phases. The generated results
were divided into ﬁve experimental phases as follows:
(1) Phase 0 and Phase 1 (Fig. 8A. Participants were ini-
tially provided with four wild-type experiments and
four experiments in which gene GLC7 was knocked
out. Thus, a total of eight microarray measurements
were initially provided. Four microarray measure-
ments were provided for each experimental condi-
tion, as is common in microarray studies. The
GLC7 knock-out experiment was initially provided
because it totally shuts down the cell system. To
view the microarray measurements that are provided
initially, and as well as the requested microarray
measurements after each phase, the control group
was provided with a graphical interface that displays
gene expression levels in grayscale dots (call this the
window GRAYSCALE_DOT window), which is
shown in Fig. 9. The intervention group was provid-
ed with a causal analysis result from GEEVE (see
Fig. 13) along with the GRAYSCALE_DOT
window.
Fig. 9. Experimental result display window, which is called GRAYSCALE_DOT. Each dot represents the gene expression level of a gene that is listed at
represents the experimental condition in which REG1 was knocked out).
lts of that phase. They can slide the FOLD_CHANGE bar to mark (with ‘‘’’
and ‘‘+’’ signs) the signiﬁcant observed changes on the gray scale dot. The ‘‘·’’ marked dots indicate those experimental results that are not avialable at
this time.
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Participants can choose any phase in the top right corner and view the resu• In each phase, participants in the intervention group
were required to follow GEEVEs recommendations
for which experiments to perform (detail in Fig. 10).
This requirement was relaxed slightly in Phases 1
and 2, where participants could select among two
experimental design choices generated by GEEVE.
As described in Chapter 4, the experimental design
recommendations by GEEVE were based on an
expected value of information calculation and it
used all of the microarray data that had been gath-
ered up to the current point of analysis. An experi-
mental design consisted of a speciﬁcation of (1) a
selected pair (X,Y) of genes to focus on, and (2)
how many microarray experiments (conditions) to
perform with those genes, where an individual
experiment could involve either knocking out X
and measuring Y, knocking out Y and measuring
X, or just measuring X and Y without knocking
out either one of them (the wild-type experiment).
The total number of microarray experiments thatcould be performed in a single phase was 10. As stat-
ed previously, the total number of microarray exper-
iments over all the phases was allowed to be up to
50. The window that the participants used in the
intervention group is shown in Fig. 11. The left table
of the experiment request window (in Fig. 11) is the
list of causal predictions of LIM and upper right
corner table shows the experimental recommenda-
tions from GEEVE. Note that because of limited
biological variation that is presented in current
microarray technology [55], by default, we do not
display the analysis results of the latent confounded
relationships (Fig. 11). We display only, for exam-
ple, the best recommendation of GEEVE is to carry
out one wild-type experiment, three REG1 knock-
out experiments, and three SNF4 knock-out experi-
ments. Recall from Section 2.3 that GEEVE models
three diﬀerent types of experiments: (1) a wild-type;
(2) a knock-out of Gene1; and (3) a knock-out of
Gene2. Participants could indicate an experimental
preference that diﬀered from the recommendation
Fig. 11. Experiment request window (intervention group). Participants in the intervention group could select from GEEVE recommendations, which are
displayed in the top right table. See main text for detail descriptions of the contents in the window.
Fig. 10. Generated scenarios of GEEVE recommendations for the intervention group. In Phases 1 and 2, participants are given the option to choose
between the best recommendation and the next best recommendation. After Phase 3, participants are asked to follow only the best recommendation of
GEEVE. Contents within the parentheses represent recommendations of GEEVE in the form (GeneX, GeneY, NWT, NXK, and NYK) where GeneX and
GeneY represent a gene pair, NWT represents the number of wild-type experiments, NXK represents number of GeneX knock-out experiments, and NYK
represents number of GeneY knock-out experiments.
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(microarray experiments) in the text box on the
lower right corner), but this information was logged
only and did not inﬂuence the experimental simula-
tions actually performed (as shown by the path of
phases in Fig. 10).
• Participants in the control group could have GEEVE
perform (via a simulation) any experiment they
desired. As with the intervention group, the totalnumber of microarray experiments that could be
performed in a single phase was 10, and the total
number of microarray experiments over all the phas-
es was allowed to be up to 50. In designing their
experiments, the control group participants had
electronic access to all of the previous microarray
data that had been gathered up to the current point.
The window that the participants used in the control
group is shown in Fig. 12.
Fig. 12. Experiment request window (control group). Participants in the control group could request up to 10 measurements in three diﬀerent experiments.
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pants in the study that described (1) a general overview
of the study; (2) the system used in the control group;
and (3) the GEEVE system used in the intervention group.
After the introductory session, participants were randomly
placed either in the control or intervention groups. All par-
ticipants were asked to download an appropriate program
via a designated study website and to use an email attach-
ment to send their results back to me within a week. Three
participants needed more than a week to respond. All par-
ticipants responded within two weeks.
Since a typical GEEVE analysis of a single microarray
result takes 3–4 h, it was not practical to ask the partici-
pants in the intervention group to wait that long for a rec-
ommendation. Thus, we precomputed and cached diﬀerent
experimental scenarios that the user could follow in this
study. As shown in Fig. 10 only a limited number of exper-
imental options were available to the user, because of lim-
ited time to pre-compute them.
Thus, when a user selected one of these experiments,
GEEVE could almost instantly retrieve the data from that
simulated experiment as well as its causal analysis of that
data. We selected the experimental scenario choices as
those that, according to GEEVE, had the lowest expected
cost/beneﬁt ratio, where beneﬁt is the term calculated byevaluating the decision tree in Fig. 5. As stated in Section
2.3, GEEVE incorporates experimenters preferences
among the gene pairs and calculates the cost of the exper-
iments. Note that since GEEVE recommendations were
precompiled in this study (Fig. 10), the preferences were as-
sessed from Dr. Schmidt and the same preferences were
provided to all participants in the study; each participant
was asked to adopt those preferences as his or her own.
Using those features, GEEVE recommends which experi-
mental condition to consider, i.e., which gene to knock-
out, and how many microarray experiments to perform.
For example, let us assume that after analyzing the initial
data, GEEVE calculates that knocking out REG1 and
observing expression levels of all other genes may be the
best experiment to perform. Additionally, GEEVE recom-
mends doing three repetitions of this experiment. If the
user wants to follow the best recommendation, GEEVE
would then fetch the analysis result from the appropriate
precalculated conﬁguration, e.g., Phases 2–1 in Fig. 10.
The knock-out experiments in both the intervention and
the control groups were limited to a single knock-out of
one of the nine genes (excludingSSG) shown inFig. 13.After
each phase, each participant was asked to give his or her
probability assessment of the causal relationships among
the genes that the participant had initially selected as being
Fig. 13. Evaluation window. Participants in control and intervention groups were asked to assess their beliefs on 10 prespeciﬁed gene pairs after each
phase. All participants were given the same gene pairs and asked to adopt the preferences that are shown in the upper right corner. Preferences on gene
pairs were assessed from Dr. Schmidt.
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was used to obtain these assessments. The resources (i.e.,
participants time to ﬁnish the study and the number of
experimental and observational cases) used by each individ-
ual to predict the causal relationships were also recorded.
There was a baseline (before the study) and a follow-up
(after the study) computer-based questionnaire given to
each participant to assess his or her belief about the causal
relationships among the 10 genes in the domain of study
(see Fig. 13). The participants beliefs at baseline are tagged
as Phase 0 beliefs. The information from these question-
naires is summarized in the next section.
The following results use ROC curves to characterize the
discovery performance of each participant on Dr.
Schmidts preferences among 10 pairwise genes shown in
Fig. 13 (Note the preferences are shown in the upper right
table). To assess Dr. Schmidts preferences, we randomly
selected 20 gene pairs and asked Dr. Schmidt to express
his preference among the gene pairs (Dr. Schmidt was alsoasked to add or drop any gene pairs of the 20 gene pairs we
have selected). Before conducting the actual study we have
asked my colleagues to test the program that was used in
the actual study. Colleagues who participated in the preli-
minary testing of the program stated that evaluating 20
gene pairs was simply too much. So, out of the 20 gene
pairs, we selected 10 gene pairs to get a mixture of 4 gene
pairs for which Dr. Schmidt had relatively high preferences
(>0.6) and 6 gene pairs for which he had relatively low
preferences (<0.6). These preferences were weighted in cal-
culating the AUROC for each participant in each phase,
i.e., for all R 2 {10 pairwise relationships}, we calculate:
1
10

X
R
UðRÞ AUROCðRÞ; ð3Þ
where U (R) represents the preference of R and AUR-
OC(R) denote the area under the ROC curve for a predic-
tion that involves R. We also compare the resources that
the participants in each group used.
Table 2
Information about the participants in the intervention and control groups
Professor Post doc Ph.D. student (>3rd year) Ph.D. student (6 3rd year) Others* Total
(a) Positions. *Others include a technician with a Masters degree in a ﬁeld other than biology
Control group 1 0 2 1 1 5
Intervention group 1 1 1 2 0 5
Understand well Understand somewhat Know only the genes Totally ignorant Total
(b) Knowledge in SNF1 pathway
Control group 0 2 3 0 5
Intervention group 0 1 4 0 5
Understand well Understand somewhat Totally ignorant Total
(c) Knowledge in cDNA microarray technology
Control group 0 5 0 5
Intervention group 1 4 0 5
Average Standard deviation p value
(d) Subjective self-evaluation of computer expertise using the following values: 0 = Novice, 0.5 = Intermediate, 1.0 = Expert.p value to reject hypothesis H0:
l1 = l2 where l1 represents the mean of subjective self-evaluation of computer expertise in the intervention group and l2 represents the mean of the same value
in the control group
Control group 0.56 0.13 0.34
Intervention group 0.60 0.16
138 C. Yoo et al. / Journal of Biomedical Informatics 39 (2006) 126–1464.2.3. Control study results
Table 2 shows more information about the participants
in the control and intervention groups. The 10 participants
were selected based on their knowledge of the SNF1 path-
way and cDNA microarray technology. Table 2 shows that
participants were equally distributed based on their posi-
tions, knowledge of the SNF1 pathway, knowledge of
cDNA microarray technology, and their expertise in com-
puters (see Appendix A for the pre-study questionnaire).
This is because we stratiﬁed the participants into the inter-
vention and control groups to balance the dimensions in
Table 2 as much as possible.
Fig. 14 plots the AUROC curves to characterize the dis-
covery performance of each group. The intervention group
starts at Phase 0 with lower prediction performance in
independence and causal predictions than the control
group. At the end of Phase 5, the intervention group per-
forms better than the control group in independence and
causal predictions. No p values to reject hypothesis
l1 = l2
3 were lower than 0.05.4 In other words, we cannot
reject the hypothesis l1 = l2 with high conﬁdence
(p 6 0.05) in any phase. Although the diﬀerences were
not strongly diﬀerent statistically, Fig. 14 shows a trend
in which the intervention group generally performs better
(except in Phase 3) than the control group.
Fig. 14 plots the comparison of the two groups in each
phase without considering the number of microarray
experiments that the participants in the two groups per-
formed (via the SR Simulator). Fig. 15 incorporates that
number. In particular, it displays the AUROC per micro-3 where (1) l1 represents the mean of AUROC in the intervention group
for causal or independence prediction; and (2) l2 represents the mean of
AUROC in the control group for causal or independence prediction.
4 The hypotheses testing analyses in this chapter uses the two-sample t
test [56].array experiment (this unit represents an increased fraction
of an AUROC that an experimenter is willing to gain per
microarray experiment) for each phase showing plots for
the intervention and the control groups.
There are diﬀerent suggested protocols to analyze a
microarray chip [57]. Consulting a technician at the Vir-
ginia Bioinformatics Institute, we were told that it usually
takes 16 h (two days) of a technicians time to produce
and analyze one microarray chip. We were also told that
it will usually take 20 and 24 h for him or her to analyze
two and three cDNA microarray chips at once respective-
ly (4 h for each additional microarray chip). This is be-
cause it usually takes 4 h to ﬁnish the ﬁrst step,
extracting DNA. If the technician earns $20 per hour,
the costs involved in analyzing two chips in the two diﬀer-
ent scenarios are: (1) $640 to analyze one chip at a time
((16 h · 2) · $20); and (2) $400 to analyze two chips at
once (20 h · $20). Similarly, the costs involved in analyz-
ing three chips are: (1) $960 to analyze one chip at a time
((16 h · 3) · $20); and (2) $480 to analyze three chips at
once (24 h · $20). We use a function that models the ex-
pect time to complete microarray experiments, i.e.,
f (x) = 4x + 12, for x > 1, where x is the number of micro-
array experiments requested. Then the cost function be-
comes C (x) = $20 Æ f (x). Results that incorporate the
estimated costs involved in performing an experiment
are shown in Fig. 16. The resulting trends are similar to
Fig. 15, but with even more of a diﬀerence between the
intervention group and the control group.
The p value to reject the null hypothesis l1 = l2, where
l1 represents the mean of AUROC/case in the intervention
group and l2 represent the mean of AUROC/case in the
control group, is shown in Table 3. Table 3 shows that
intervention group has a modestly statistically signiﬁcant
diﬀerence from the control group in Phases 2, 4, and 5.
Fig. 14. Area under ROC (AUROC) of the control and intervention groups. Each bar represents a 95% conﬁdence interval.
Fig. 15. Area under ROC (AUROC) per experiment for the control and intervention groups. Each bar represents a 95% conﬁdence interval. (A) AUROC
per experimental case (microarray experiments) for independence relationship predictions (B) AUROC per experimental case (microarray experiments) for
causal relationship predictions.
C. Yoo et al. / Journal of Biomedical Informatics 39 (2006) 126–146 139
Fig. 16. Area under ROC (AUROC) per cost of the control and intervention groups. Each bar a represents a 95% conﬁdence interval. (A) Independence
relationship predictions: AUROC divided by cost. (B) Causal relationship predictions: AUROC divided by cost.
Table 3
p value to reject the hypothesis H0: l1 = l2 where l1 represents the mean of AUROC in the intervention group and l2 represents the mean of AUROC in
the control group
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
Independence prediction 0.39 0.08 0.14 0.11 0.20
Causal prediction 0.07 0.04a 0.14 0.02a 0.04a
a Statistically signiﬁcant results to support l1 > l2.
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pairs that had higher than 0.7 user preference levels (see
the upper right table of Fig. 13 for the four gene pairs
and recall that GEEVE incorporates an experimenters
preferences for which genes to study). We are concentrat-
ing on these four gene pairs because they represent a group
of gene pairs that each experimenter is relatively more
interested in. The intervention group performed statistical-
ly signiﬁcantly better than the control group (p 6 0.05) in
Phases 2, 4, and 5. Fig. 17 shows that using GEEVE with
such preferences performed better in causal relationship
prediction than an experimenter without using GEEVEs
preferences, especially when there were a limited number
of microarray measurements.Fig. 18 shows Fig. 14 in a diﬀerent way. It calculates the
increase of AUROC in each phase. For example, the value
in Phase 2 in Fig. 18A represents the AUROC increase
from Phases 1 to 2 in Fig. 14. It shows that the increase
of causal predictions (Fig. 18B) of the intervention group
was statistically signiﬁcantly better than that of the control
group in Phases 1 and 4.
Table 4A shows the diﬀerence of the control group and
intervention group in terms of average number of micro-
array experiments obtained among the participants to ana-
lyze the data. Table 4B shows the average time the
participants spent during the simulated experiments.
Although no statistically signiﬁcant diﬀerence was noticed
between the two groups, intervention group used the
Fig. 17. Area under ROC (AUROC) per case (microarray experiments) of the control and intervention groups considering only gene pairs with a user
preference higher than 0.7. Each bar represents a 95% conﬁdence interval. (A) AUROC per case (microarray experiments) of independence relationship
predictions. (B) AUROC per case (microarray experiments) of causal relationship predictions.
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obtained and the total amount of time spent) more eﬃcient-
ly. Only ﬁve participants responded to the follow-up ques-
tionnaire which is shown in full in Appendix B. The results
are shown in Table 4C; no statistically signiﬁcant preference
diﬀerence was found between the two diﬀerent result display
methods which is not surprising given the small sample size.
Although it was not statistically signiﬁcant, the interven-
tion group showed a trend to perform better than the con-
trol group (Fig. 14) while requesting a smaller number of
experiments Table 4A. It may be diﬃcult to clearly specify
precisely why such trends were observed in this limited
study. However, there are some diﬀerences that are ob-
served between the two study groups.
First, as shown in Fig. 10, whatever path the participa-
tions in the intervention group take, they eventually perform
eight diﬀerent knock-out experiments, and thus, they do not
perform all possible knock-out experiments. For example, if
a participant follows a branch that includes Phases 3–3 in
Fig. 10, then he or she did not perform a SNF1 knock-out
experiment (note that GLC7 knock-out experiments were
initially provided). In the control group 3 (out of 5) partici-
pants performed all 9 possible knock-out experiments.This indicates that in the control group many participants
preferred a complete experimental design, i.e., an experimen-
tal design with all possible knock-out experiments.
Second, as shown in Fig. 10, the number of experiments
requested in the intervention group varies within diﬀerent
phases. For example, if a participant follows a branch that
includes Phases 3–2 in Fig. 10, then he or she ends up
requesting 7, 8, 10, and 7 experiments for Phases 2, 3, 4,
and 5, respectively, [we denote these sequence of requests
as (7, 8, 10, and 7)]. In the control group, 2 participants
requested the same number of experiments for all the phas-
es [(9, 9, 9, and 9) and (10, 10, 10, and 10)] and others
showed the following sequence of requests: (9, 10, 10,
and 10), (9, 10, 10, and 10), and (9, 8, 6, and 6). This indi-
cates that participants in the control group requested the
number of experiments mostly based on the maximum
number of experiments that they could request.
5. Conclusions
Systems biology emphasizes large scale discovery of the
interactions of genes, proteins, and other cell elements. Sys-
tems biology is confronted with a huge number of interac-
Fig. 18. Diﬀerence in AUROC between phases. Each bar represents a 95% conﬁdence interval. (A) AUROC diﬀerence between phases of independence
relationship predictions. (B) AUROC diﬀerence between phases of causal relationship predictions.
Table 4
Resource used in both groups and feedback of the causal analysis result window from GEEVE (Fig. 13) and the GRAYSCALE_DOT window (Fig. 9)
Average Standard deviation p value
(a) Number of experiments requested. p value to reject hypothesis H0: l1 = l2 where l1 represents the mean of the number of experiments requested in the
intervention group and l2 represents the mean of the number of experiments requested in the control group.
Control group 45.2 5.31 0.11
Intervention group 41.8 0.45
(b) Total time spent in the study (seconds). p value to reject hypothesis H0: l1 = l2 where l1 represents the mean of time spent for overall study in the
intervention group and l2 represents the mean of time spent for overall study in the control group. Note that this is a rough estimate because we cannot
guarantee whether a user was working on the control study all the time that the system window was open.
Control group 4519.00 2509.65 0.27
Intervention group 3388.00 422.96
(c) Subjective evaluation of GRAYSCALE_DOT and GEEVE causal output. Subjective values used are: 0.0 = not helpful at all, 0.25 = somewhat not helpful,
0.5 = indiﬀerence, 0.75 = somewhat helpful, 1.0 = very helpful
Control group GRAYSCALE_DOT 0.83a 0.14
Intervention group GRAYSCALE_DOT 0.62b 0.53
GEEVE result 0.75b 0
a Based on three responses.
b Based on two responses (no free text comments were provided in all responses).
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are challenges in designing high throughput experiments,
such as cDNA microarrays, and for analyzing the high vol-
ume of data generated by those experiments to discover generegulation networks. Intrinsically, these issues are causal in
nature. We have introduced a new causal analysis method
along with a computer system that uses that method to rec-
ommend the gene-regulation experiments to perform.
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experimenter is interested in the causal relationship of a
handful variables (e.g., an experimenter is interested in a
new drug and its treatment eﬀect) in systems biology an
experimenter is usually interested in the causal relation-
ships among thousands of entities, such as genes. Diﬀerent
approaches are needed in systems biology for causal dis-
covery and experimental design recommendation. This pa-
per has explored one such approach. In the remainder of
this section, we summarize the contributions made by this
paper and then discuss open problems.
5.1. Local causal search with experimentation
recommendations
We developed a system called GEEVE that incorporates
an experimenters preferences regarding which genes to
study to discover causal relationships among those genes.
Among the genes of interest, GEEVE models their likely
causal relationships, based on prior biological knowledge
and experimental data.
Experiments provide beneﬁt in terms of information,
but they also have costs in terms of human labor and the
laboratory costs. Considering preferences, costs, and a cur-
rent model of causal relationships, GEEVE recommends
the most cost-eﬀective experiment it can ﬁnd in its search
of the space of experiments.
We conducted a randomized controlled study that in-
volved 10 biologists who are familiar with the SNF1 path-
way in yeast. This study showed that most of the time the
intervention group performed better—although not always
statistically signiﬁcantly so—than the control group in pre-
dicting whether pairs of genes (of interest to the biologist
study participant) act independently or have a causal rela-
tionship. It also showed that the intervention group de-
signed experiments more eﬃciently than the control
group by not selecting gene pairs and number of experi-
ments using a blocked design with a maximum allowed
number of experiments, which appears to be the design
most commonly used by participants in the control group.
Calculating the predictive performance (area under
ROC curve) per (simulated) experiment performed, the
intervention group showed better results, some of which
were statistically signiﬁcant, than did the control group.
These results suggest that GEEVE did improve the eﬃcien-
cy of the intervention group in discovering causal relation-
ships among the genes of interest.
5.2. Future work and open issues
Regarding external experimental conditions, such as
nutrient conditions, they could be modeled as exogenous
variables in a causal Bayesian network. Currently, GEEVE
models only experiments that involve wild-type gene levels
and single gene knock-outs. In the future, more general
experiments, such as over-expression experiments, more
than one gene knock-out and so forth, should be modeled.Regarding modeling the time course of gene expression,
and determining precisely when to sample cells during
experimentation, temporal Bayesian networks appear a
natural choice [58,59]. It will be interesting to explore mod-
els that use both continuous and discrete variables within
temporal Bayesian networks. Temporal Bayesian networks
also provide one approach to modeling gene regulation
feedback. The six pairwise causal hypotheses used in this
research could be extended to model such feedback. This
is an important issue for future research because feedback
is widely observed in many cellular pathways.
Currently GEEVE only generates decision trees based
on the discovery of pairwise gene relationships. More gen-
erally, Rj in Fig. 5 (Section 2.3) should include more than
pairwise relationships. Doing so will allow GEEVE to (1)
model beyond a single gene perturbation experiments, such
as a knock-out of two or more genes at a time; and (2)
incorporate (in the decision tree) the eﬀects on other genes
besides genes (X,Y) when gene X (or Y) is perturbed.
We have also introduced a causal discovery system that
can score latent structures. Since the most closely related
prior methods assume no latent variables, there is no
straightforward way to evaluate GEEVEs prediction of la-
tent structures with these other methods. Also since cDNA
microarray is measuring the average expression level of
millions of cells, the variance that we observe in the levels
(when an experiment is repeated several times) is due al-
most entirely to measurement error and not to biological
variation [55]. Biological variation is needed to discover la-
tent structure, certainly with LIM, and we believe with any
method. Measuring the expression level of genes under var-
ious experimental conditions (e.g., measuring at diﬀerent
time points or in diﬀerent temperatures) can provide bio-
logical variation among groups of cells; it is an open ques-
tion how helpful biological variation of this particular
variety will be in discovery of latent structure.
Another way to obtain biological variation in gene
expression would be to measure gene expression at the level
of a single cell. Such measurements will require new tech-
nology. We anticipate that such methods will be developed
within the next decade. If so, the methods in this paper will
be applicable to suggesting when latent factors (such as un-
known proteins) may be inﬂuencing two or more speciﬁc
genes.
Due to time and budget constraints, the evaluation
reported in this paper only addresses an initial, limited
set of issues. For example, the study does not answer the
following question: How would the participants in the
intervention group perform if they were placed in the con-
trol group? Such a cross-over design could be conducted by
extending the present study to include a diﬀerent simula-
tion pathway network. In this additional study, we would
ask participants in the intervention group of the current
study (reported herein) to participate in the control group
in the additional study and vice versa.
Many other ways to improve the controlled study can be
considered, such as:
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er matching of the control and intervention groups in
terms of their knowledge of the SNF1 pathway. We
expect that having additional participants also will
tighten the conﬁdence intervals in the AUROC
analyses.
(2) Providing more personal attention to each partici-
pant. We could have visited each participant person-
ally and spent the entire time with him/her during
his/her participation in the study. In this case, we
could have asked all the post-study questions imme-
diately after the participant completed using the
study.
(3) Having an independent person conducting the intro-
ductory session. This would remove the chance that I,
as the developer of GEEVE, might unintentionally
have biased training in a way that favors the partici-
pants view of GEEVE.
This paper presents only an initial study of the causal
analysis and experimental design modules of GEEVE.
Clearly, much more extensive testing can be done using
simulated data and real data. When GEEVE is suﬃciently
reﬁned, it would be interesting to make it available as a
web-based system and let biologists submit their micro-
array data along with their preferences to GEEVE and
then receive the analysis results online or via e-mail. To
accomplish this, it might be helpful to use already devel-
oped hypothesis ontology [60,61].
Ideker et al. [31] describe four steps in discovering causal
pathways among the genes: (1) gather and formulate the
current knowledge about the genes and their pathways;
(2) design and perform experiments; (3) analyze the data
from the experiments; and (4) formulate new hypotheses
to explain the analysis results not predicted by Step 1
and then repeat steps 2, 3, and 4. There are many open is-
sues in how to complete this loop. The soundness of micro-
array measurements needs to be studied further, e.g.,
studying the relationship between mRNA levels and pro-
tein expression levels, and studying and quantifying the
various sources of measurement error related to detecting
gene expression levels. Other open issues include detecting
genes and their promoter regions from sequence informa-
tion, compiling known gene regulatory knowledge (and
other cell-network knowledge) from the literature, and
standardizing causal pathway representations to interact
with interaction with existing databases of biological path-
ways, e.g., KEGG [62], and WIT [63].
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(NRA2-37143).Appendix A. Pre-study questionnaire
Thank you for your interest in participating in a study
that involves designing and analyzing simulated cDNA
microarray experiments in yeast. I am writing to ask the
following six brief questions, which should take a total of
less than a minute of your time. Your responses will be very
helpful in guiding the selection of the best balance of par-
ticipants for the study. I hope to be back in contact with
you soon.
Thank you.
Changwon Yoo
1. To what degree are you familiar with cDNA microarray
technology? _____
A = Not familiar with cDNA microarray technology.
B = Understand the basic idea of cDNA microarray
technology but not the details.
C = Understand the concept of cDNA microarray tech-
nology well.
2. Have you ever analyzed a dataset of a cDNA microarray
study (yes/no)? _____
3. Have you ever designed a cDNA microarray study (yes/
no)? _____
4. Have you ever carried out a cDNA microarray study in
the lab (yes/no)? _____
5. To what degree are you familiar with the gene regulation
pathway involving SNF1 protein kinase in yeast? _____
A = Know nothing about the pathway.
B = Know some genes involved in the pathway but do
not know about the pathway.
C = Know some genes involved in the pathway and
some knowledge about the pathway.
D = Know most of the genes involved in the pathway
and some knowledge about the pathway.
6. How would you rate your level of computer expertise?
(0 = Novice, 0.5 = Intermediate, 1.0 = Expert)
7. Please choose one of the following that best describes
you. _____
A = Masters degree student.
B = Masters degree holder but not a doctoral
student.
C = Doctoral student (3 or less years in the
program).
D = Doctoral student (more than 3 years in the
program).
E = Post doc.
F = Faculty member (assistance professor or higher).
G = Other (please specify).
Appendix B. Follow-up questionnaire
Thanks for your participation in the control study. I am
writing to ask the following four brief questions. Your
responses will be very helpful in analyzing the study.
Thank you.
Changwon Yoo
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expression level (analysis results displayed in grayscale
dots in a separate window)? If yes, please describe them
brieﬂy (free text)?
• Were the programs display of the gene expression levels
helpful in learning the causal relationships between the
genes (values between 0.0 and 1.0, 0.0 = not helpful at
all, 0.25 = somewhat not helpful 0.5 = indiﬀerence,
0.75 = somewhat helpful, 1.0 = very helpful)?
• Did you experience any diﬃculties interpreting the pro-
grams causal predictions (analysis results displayed in
‘‘CAT8->JEN1 0.823’’ format in the Evaluation Win-
dow) (yes/no)? If yes, please describe them brieﬂy (free
text)?*
• Were the programs causal predictions helpful in learning
the causal relationships between the genes (values
between 0.0 and 1.0, 0.0 = not helpful at all, 0.25 = some-
what not helpful 0.5 = indiﬀerence, 0.75 = somewhat
helpful, 1.0 = very helpful)?*
• Any other comments (free text)?
*Only asked to the intervention group.References
[1] Cooper GF, Herskovits E. A Bayesian method for the
induction of probabilistic networks from data. Mach Learn
1992;9:309–47.
[2] Heckerman D. A Bayesian approach to learning causal networks. In:
Proceedings of the conference on uncertainty in artiﬁcial intelligence.
Morgan Kaufmann; 1995. p. 285–95.
[3] Spirtes P, Glymour C, Scheines R. Causation, prediction, and search.
2nd ed. Cambridge, MA: MIT Press; 2000.
[4] Bay SD, Shrager J, Pohorille A, Langley P. Revising regulatory
networks: from expression data to linear causal models. J Biomed
Inform 2002;35:289–97.
[5] Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approach to
randomized trials. J R Stat Soc 1994;157(Part 3):357–416.
[6] Berry DA, Stangl DK. Bayesian methods in health-related research.
In: Berry DA, Stangl DK, editors. Bayesian biostatistics. New
York: Marcel Dekker; 1996. p. 3–66.
[7] Friedman LM, Furberg CD, DeMets DL, Chapter 7. Sample size, In:
Fundamentals of clinical trials. 3rd ed. Mosby-Year book: St. Louis;
1996. p. 94–129.
[8] Karp PD, Krummenacker M, Paley S, Wagg J. Integrated pathway/
genome database and their role in drug discovery. Trends Biotechnol
1999;17(7):275–81.
[9] Kerr MK, Churchill GA. Experimental design for gene expression
microarrays. Biostatistics 2001;2:183–201.
[10] Karp RM, Stoughton R, Yeung KY. Algorithms for choosing
diﬀerential gene expression experiments. Res Comput Biol
1999:208–17.
[11] Ideker T, Thorsson V. Karp RM. Discovery of regulatory interac-
tions through perturbation: inference and experimental design. In:
Paciﬁc symposium biocompution. 2000. p. 305–16.
[12] Tong S, Koller D. Active learning for structure in Bayesian networks.
In: International joint conference on artiﬁcial intelligence. Seattle;
WA: 2001.
[13] Brown PO, Botstein D. Exploring the new world of the genome with
DNA microarrays. Nat Genet 1999;21(Suppl):33–7.
[14] Lipshutz RJ, Fodor SPA, Gingeras TR, Lockhart DJ. High density
synthetic oligonucleotide arrays. Nat Genet 1999;21(Suppl):20–4.[15] Yoo C, Cooper G. Discovery of gene-regulation pathways using local
causal search. In: AMIA. San Antonio, Texas; 2002. p. 914–8.
[16] Pearl J. Probabilistic Reasoning in Intelligent Systems. In: Brachman
RJ, editor. Representation and reasoning. San Mateo, CA: Morgan
Kaufmann; 1988.
[17] Heckerman D, Geiger D, Chickering D. Learning Bayesian networks:
the combination of knowledge and statistical data. Mach Learn
1995;20:197–243.
[18] Yoo C, Thorsson V, Cooper GF. Discovery of a gene-regulation
pathway from a mixture of experimental and observational DNA
microarray data. In: Paciﬁc symposium on biocomputing. Maui,
Hawaii: World Scientiﬁc: 2002. p. 498–509.
[19] Yoo C, Cooper G. Causal discovery of latent-variable models from a
mixture of experimental and observational data. In: Center for
Biomedical Informatics Research Report CBMI-173. Center for
Biomedical Informatics: Pittsburgh, PA: 2001.
[20] Yoo C, Expected value of experimentation in causal discovery from
gene expression studies. Ph.D. dissertation, 2002.
[21] Henrion M. Propagating uncertainty in Bayesian networks by
probabilistic logic sampling. In: Lemmer JF, Kanal LN, editor.
Uncertainty in artiﬁcial intelligence 2. North-Holland, Amsterdam.
1988. p. 149–63.
[22] Heckerman D, Horvitz E, Middleton B. An approximate non-myopic
computation for value of information. In: Proceedings of the Seventh
Conference on Uncertainty in Artiﬁcial Intelligence. 1991.
[23] Chavez T, Henrion M. Eﬃcient estimation of the value of informa-
tion in Monte Carlo models. In: Uncertainty in artiﬁcial intelligence.
1994. p. 119-27.
[24] Yoo C, Cooper G. An evaluation of a system that recommends
microarray experiments to perform to discover gene-regulation
pathways. J Artif Intell Med 2004;31:169–82.
[25] von Neumann J, Morgenstern O. Theory of games and economic
behavior. Princeton, NJ: Princeton University Press; 1944.
[26] Keeney RL, Raiﬀa H. Decisions, with multiple objectives: preference
and value tradeoﬀs. New York: John Wiley; 1976.
[27] Achcar JA. Use of Bayesian analysis to design of clinical trials with
one treatment. Commun Stat Theory Methods 1984;13:1693–707.
[28] Pearl J. Causality: models, reasoning, and inference. Cambridge,
UK: Cambridge University Press; 2000.
[29] Heckerman D, Meek C, Cooper GF. A Bayesian approach to causal
discovery. In: Glymour C, Cooper GF, editors. Computation
causation and discovery. Menlo Park, CA: AAAI Press; 1999. p.
141–65.
[30] Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen
MB, et al. Comprehensive identiﬁcation of cell cycle-regulated genes
of the yeast Saccharomyces cerevisiae by microarray hybridization.
Mol Biol Cell 1998;9:3273–97.
[31] Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Bumgarner
R, et al. Integrated genomic and proteomic analysis of a systemat-
ically perturbed metabolic network. Science 2001;292:929–34.
[32] Michaels GS, Carr DB, Askenazi M, Fuhrman S, Wen X, Somogyi R.
Cluster analysis and data visualization of large-scale gene expression
data. In: Paciﬁc symposium on biocomputing. 1998. p. 42–53.
[33] Herwig R, Poustka AJ, Muller C, Bull C, Lehrach H, OBrien J.
Large-scale clustering of cDNA-ﬁngerprinting data. Genome Res
1999;9:1093–105.
[34] Golub TR, Slonim DK, Tamayo P, Huard C, Caasenbeek M,
Mesirov JP, et al. Molecular classiﬁcation of cancer: class discovery
and class prediction by gene expression monitoring. Science
1999;286:531–7.
[35] Bushel PR, Hamadeh HK, Bennett L, Green J, Ableson A, Misener
S, et al. Computational selection of distinct class- and subclass-
speciﬁc gene expression signatures. J Biomed Inform 2003;35:160–70.
[36] Tsang J. Gene expression, DNA arrays, and genetic network. In:
Unpublished manuscript Bioinformatics Laboratory at University of
Waterloo. 1999.
[37] Dutilh, B. Gene networks from microarray data. In: Unpublished
manuscript. Literature thesis at Utrecht University. 1999.
146 C. Yoo et al. / Journal of Biomedical Informatics 39 (2006) 126–146[38] de Jong H. Modeling and simulation of genetic regulatory systems: a
literature review. J Comput Biol 2002;9(1):67–103.
[39] Friedman N. Inferring cellular networks using probabilistic graphical
models. Science 2004;303(5659):799–805.
[40] Smolen P, Baxter DA, Byrne JH. Modeling transcriptional control in
gene networks—methods, recent results and future directions. Bull
Math Biol 2000;62:247–92.
[41] Chu T, Glymour C, Scheines R, Spirtes P. A statistical problem
for inference to regulatory structure from associations of gene
expression measurement with microarrays. Carnegie Mellon Uni-
versity; 2003.
[42] Shrager J, Langley P. Computational models of discovery and theory
formation, In: Shrager J, Langley P, editor. San Mateo, CA: Morgan
Kaufman; 1990.
[43] Karp PD. Hypothesis formation as design. In: Shrager J, Langley P,
editors. Computational models of discovery and theory forma-
tion. San Mateo, CA: Morgan Kaufman; 1990. p. 276–317.
[44] Cooper GF, Yoo C. Causal discovery from a mixture of experimental
and observational data. In: Proceedings of the conference on
uncertainty in artiﬁcial intelligence. Morgan Kaufmann; 1999. p.
116–25.
[45] Akutsu T, Miyano S, Kuhara S, Identiﬁcation of genetic networks
from a small number of gene expression patterns under the Boolean
network model. In: Paciﬁc symposium on biocomputing. Hawaii:
1999. p. 17–28.
[46] Tomita M, Hashimoto K, Takahashi K, Shimizu T, Matsuzaki Y,
Miyoshi F, et al. E-CELL: software environment for whole cell
simulation. Bioinformatics 1999;15(1):72–84.
[47] Scheines R. Ramsey J. Gene simulator. 2001: Available from: http://
www.phil.cmu.edu/projects/tetrad/tetrad4.html.
[48] Saavedra R, Glymour C. A regulatory network simulator. In:
Simulator based on (Yuh et al. 1998) under development. 2001.
[49] Edwards R, Glass L. Combinatorial explosion in model gene
networks. Chaos 2000;10:691–704.
[50] Kauﬀman S. Origins of order—self-organization and selection in
evolution. Londan: Oxford University Press; 1993.
[51] McCartney R, Schmidt M. Regulation of Snf1 kinase. Activation
requires phosphorylation of threonine 210 by an upstream kinase aswell as a distinct step mediated by the Snf4 subunit. J. Biol. Chem.
2001;276(39):36460–6.
[52] Schmidt M, McCartney R, Zhang X, Tillman T, Solimeo H, Wolﬂ S.
Std1 and Mth1 proteins interact with the glucose sensors to control
glucose-regulated gene expression in Saccharomyces cerevisiae. Mol
Cell Biol 1999;19:4561–71.
[53] Schmidt M, McCartney R. Beta-subunits of Snf1 kinase are required
for kinase function and substrate deﬁnition. EMBO J
2000;19(18):4936–43.
[54] Gasch A, Spellman P, Kao C, Carmel-Harel O, Eisen M, Storz G,
et al. Genomic expression programs in the response of yeast cells to
environmental changes. Mol Biol Cell 2000;11(12):4241–57.
[55] Spirtes P, Glymour C, Scheines R, Constructing Bayesian network
models of gene expression networks from microarray data. In: to
appear in the Proceedings of the Atlantic symposium on computa-
tional biology, genome information systems and technology. 2001.
[56] deGroot. Probability and Statistics. Reading, Massachusetts: Addi-
son-Wesley; 1986.
[57] Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, et al. A
concise guide to cDNA microarray analysis. Biotechniques
2000;29(3):548–62.
[58] Murphy K, Mian S. Modelling gene expression data using dynamic
Bayesian networks. In: Technical report, U.B. Department of
Computer Science, Editor. 1999.
[59] Friedman N, Linial M, Nachman I, Peer D. Using Bayesian
networks to analyze expression data. J Comput Biol 2000;7:601–20.
[60] Racunas SA, Shah NH, Albert I, Fedoroﬀ NV. HyBrow: a prototype
system for computer-aided hypothesis evaluation. Bioinformatics
2004;20(Suppl. 1):257–64.
[61] Sim I, Olasov B, Carini S. An ontology of randomized controlled
trials for evidence-based practice: content speciﬁcation and evalua-
tion using the competency decomposition method. J Biomed Inform
2004;37(2):108–19.
[62] KEGG, KEGG (Kyoto encyclopedia of genes and genomes), in
Available from: http://www.genome.ad.jp/kegg/.
[63] WIT, WIT (What is there?) is a www-based system to support the
creation of function assignments made to genes and the development of
metabolic models, in Available from: http://wit.mcs.anl.gov/WIT2/.
